Shinya Tsuzuki Selected Research

Shinya Tsuzuki Research Topics

Disease

15	COVID-19 02/2024 - 09/2021
6	Infections 12/2023 - 02/2020
6	Human Influenza (Influenza) 12/2023 - 01/2018
3	Sepsis (Septicemia) 03/2024 - 08/2021
3	Communicable Diseases (Infectious Diseases) 11/2023 - 02/2020
2	Smallpox (Variola) 11/2023 - 01/2023
2	Mpox (monkeypox) 04/2023 - 01/2023
2	Common Cold 01/2023 - 02/2021
1	Pyelonephritis 02/2024
1	Hemorrhage 02/2024
1	Disease Progression 12/2023
1	Urinary Tract Infections (Urinary Tract Infection) 10/2023
1	Bacteremia 10/2023
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 06/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Renal Insufficiency (Renal Failure) 11/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2022
1	Dementia (Dementias) 11/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2022
1	Lung Diseases (Lung Disease) 11/2022
1	Obesity 11/2022
1	Post-Acute COVID-19 Syndrome 04/2022
1	Persistent Infection 04/2022
1	Whooping Cough (Pertussis) 09/2021
1	Diphtheria 09/2021
1	Tetanus 09/2021
1	Diarrhea 09/2021
1	Adenomyosis 04/2021
1	Hematoma 04/2021
1	Bronchitis 02/2021
1	Birth Weight (Birth Weights) 01/2013
1	Glucosephosphate Dehydrogenase Deficiency 01/2013
1	Hemolysis 01/2013

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 12/2023 - 10/2018
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 02/2020
3	tecovirimatIBA 11/2023 - 01/2023
3	Oxygen (Dioxygen)IBA 09/2022 - 01/2022
2	remdesivirIBA 09/2023 - 05/2022
2	favipiravirIBA 02/2023 - 06/2022
2	COVID-19 VaccinesIBA 01/2023 - 01/2023
2	FluoroquinolonesIBA 09/2021 - 01/2021
2	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2021 - 01/2018
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2024
1	Heparin (Liquaemin)FDA LinkGeneric 02/2024
1	Messenger RNA (mRNA)IBA 12/2023
1	RNA (Ribonucleic Acid)IBA 12/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 11/2023
1	Meropenem (Merrem)FDA LinkGeneric 10/2023
1	Dihydrotachysterol (AT 10)IBA 10/2023
1	Cefmetazole (Cefmetazole Sodium)FDA Link 10/2023
1	4,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA 07/2023
1	Neutralizing AntibodiesIBA 06/2023
1	Immunoglobulin G (IgG)IBA 06/2023
1	SteroidsIBA 02/2023
1	Inactivated VaccinesIBA 01/2023
1	MacrolidesIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022
1	Angiotensin Receptor AntagonistsIBA 10/2022
1	ElementsIBA 04/2022
1	Viral ProteinsIBA 04/2022
1	Interferon LambdaIBA 01/2022
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 09/2021
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 09/2021
1	ToxoidsIBA 09/2021
1	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 09/2021
1	Explosive Agents (Explosives)IBA 09/2021
1	AntigensIBA 09/2021
1	Fosfomycin FDA Link 09/2021
1	Indicators and Reagents (Reagents)IBA 08/2021
1	SeprafilmIBA 04/2021
1	C-Reactive ProteinIBA 04/2021
1	Inosine Monophosphate (IMP)IBA 01/2021
1	AminoglycosidesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 04/2020
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2013
1	Trace Elements (Biometals)IBA 01/2013
1	SeleniumIBA 01/2013

Therapy/Procedure

4	Therapeutics 03/2024 - 01/2023
2	Hysterectomy 01/2023 - 04/2021
2	Ambulatory Care (Outpatient Care) 05/2021 - 02/2020
1	Activities of Daily Living (ADL) 02/2024
1	Long-Term Care 11/2022
1	Cannula 09/2022
1	Extracorporeal Membrane Oxygenation 04/2022
1	Artificial Respiration (Mechanical Ventilation) 04/2022
1	Drug Therapy (Chemotherapy) 02/2021